MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Development of utility to evaluate a symptomatic diary of motor fluctuations of Parkinson’s disease (PD) using a smartphone application.

    H. Ohtsubo, H. Iwaki, H. Yabe, M. Nagai, M. Nomoto (Matsuyama Ehime, Japan)

    Objective: To investigate the utility of a symptomatic diary of motor fluctuations of Parkinson's disease (PD) using a smartphone application. Background: In the conference last…
  • 2017 International Congress

    The combination of clinical scales and walking measures to predict falls in Parkinson’s disease: Does the length of the prospective follow-up period matter?

    R. Vitório, R. Moraes, A. Baptista, E. Lirani-Silva, L. Simieli, D. Orcioli-Silva, F. Barbieri, L. Gobbi (Rio Claro, Brazil)

    Objective: This study aimed: (i) to identify the best combination of clinical scales and walking measures to predict falls in people with Parkinson’s disease (PD)…
  • 2017 International Congress

    Management of fragility fractures in Parkinson’s Disease (PD)

    G. Alg, A. Chatterjee (Reading, United Kingdom)

    Objective: To assess the management of osteoporotic fragility fractures in patients with PD attending a Movement disorders clinic. Background: Patients with PD have a high…
  • 2017 International Congress

    Self Perception of Dysphagia in Parkinson Disease

    A. Silbergleit, C. Sidiropoulos, R. Konnai, L. Schultz, A. Kitowski, P. LeWitt (West Bloomfield, MI, USA)

    Objective: To determine when individuals with Parkinson disease (PD) perceive impairment of swallowing as it relates to time since diagnosis.  Background: Dysphagia, and particularly silent…
  • 2017 International Congress

    CSF, plasma and saliva alpha-Synuclein in moderately advanced Parkinson’s disease cohort: the BioFIND study

    R. Alcalay, A. Amara, P. Taylor, H. Andrews, J. Goldman, T. Xi, P. Tuite, C. Henchcliffe, P. Hogarth, S. Frank, M.-H. Saint Hilaire, A. Naito, M. Frasier, V. Arnedo, A. Reimer, M. Sutherland, C. Swanson-Fischer, K. Gwinn, U. Kang (NYC, NY, USA)

    Objective: To test if alpha-synuclein (α-syn) levels in CSF, plasma and saliva predict PD status in the BioFind cohort, and to test whether α-syn levels…
  • 2017 International Congress

    Neuroprotective propensity of PTUPB, a dual inhibitor of sEH and COX-2 against rotenone induced neurotoxicity in cell line and Drosophila model of Parkinson disease

    N. Lakkappa, P. Thaggikuppe Krishnamurthy, P.D. Mirazkar, N. Lakkappa, P. Krishnamurthy, P.M.D., M.M. Srinivas Bharath, B. Hammock, S.H. Hwang (Udhagamandalam, India)

    Objective: To evaluate the potential anti-parkinson activity of PTUPB (4-(5-phenyl-3-{3-[3-(4-trifluoromethyl-phenyl)-ureido]-propyl}-pyrazol-1-yl)-benzenesulfonamide) a dual inhibitor of soluble Epoxide hydrolase (sEH) and cyclooxygenase-2 (COX-2) against rotenone induced mitochondrial dysfunction,…
  • 2017 International Congress

    3D image as a complimentary assist in patients with Parkinson’s disease

    D. Khodjieva, N. Mansurova, N. Khaydarov (Bukhara, Uzbekistan)

    Objective:  To assist patients with PD to overcome the fear of stair ascent and descent with help of 3D effect staircase  Background: Since walking on…
  • 2017 International Congress

    Falls characteristics of male and female patients with Parkinson’s disease (PD)

    G. Alg, A. Chatterjee, F. Zahir (Reading, United Kingdom)

    Objective: To compare Falls risk characteristics in male and female PD patients attending a multidisciplinary Movement disorders clinic. Background: Parkinson’s disease is commoner in males.…
  • 2017 International Congress

    Multidisciplinary intensive outpatient rehabilitation program for patients with advanced Parkinson’s disease: feasibility and primary proof of concept

    T. Gurevich, T. GAIL, n. choen, o. KADURRI, L. SHTRAIFLER, I. BADICHI, N. RIPS CASSERI (tel aviv, Israel)

    Objective: To describe as a proof of concept our experience with a multidisciplinary, intensive out-patient rehabilitation program (MIOR) for advanced PD patients. Background: Intensive, multi-dimensional…
  • 2017 International Congress

    In-patient Parkinson courses and caregiver burden

    K. Martikainen, S. Kinos, R. Marttila (Turku, Finland)

    Objective: To find out whether a 10 to 14 days group-based in-patient rehabilitation course for patients with Parkinson disease and their caregivers has any long-term…
  • « Previous Page
  • 1
  • …
  • 1497
  • 1498
  • 1499
  • 1500
  • 1501
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley